Varian gets US nod for brachytherapy planning software:
This article was originally published in Clinica
Executive Summary
Varian Medical Systems has received US FDA 510(k) clearance for an improved and faster version of its VariSeed treatment planning software for permanent seed implant brachytherapy in prostate cancer patients. VariSeed 7.1 incorporates an optional feature, called Twister. The longitudinal volume acquisition module enables doctors to use ultrasound images of the prostate that have been taken without repositioning the probe, a process that can disturb or distort the prostate and yield inaccurate images, says the Palo Alto, California firm.